Dapoxeodin 30 mg 30 Tabs Odin Pharma

Product Overview

Dapoxeodin 30 mg 30 Tabs Odin Pharma presents dapoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI) formulated as white, round, film-coated oral tablets. Each tablet delivers 30 mg dapoxetine strength with 30 tablets per retail unit, providing informed adult male buyers a clearly defined configuration suitable for structured purchasing and inventory.​

The product belongs to Odin Pharma’s pharmaceutical catalog, emphasizing precise active ingredient declaration, consistent tablet appearance, and professional packaging for specialist distribution rather than general consumer supplements. This on-demand format supports eCommerce platforms serving regulated markets where compliance, clear labeling, and batch identification remain essential.​

Dapoxeodin targets adult male consumers (18-64 years) familiar with SSRI-based products rather than broad wellness categories, focusing exclusively on commercial specifications and availability without treatment claims or usage protocols.​

Brand & Manufacturer Information

Odin Pharma produces regulated pharmaceutical compounds including dapoxetine formulations alongside performance products, maintaining consistent quality standards across oral tablet lines. Dapoxeodin features professional film-coating, precise strength declaration (30 mg), and molecular formula identification (C₂₁H₂₃NO·HCl) on labeling.​

The brand emphasizes batch traceability, standardized tablet morphology, and controlled packaging suitable for pharmacies, specialist retailers, and informed direct purchasers operating within applicable regulatory frameworks. Odin Pharma’s dual-market positioning differentiates Dapoxeodin from generic dapoxetine while supporting integration into broader men’s health or performance catalogs.​

Active Compound Information

Dapoxeodin contains dapoxetine hydrochloride, a short-acting selective serotonin reuptake inhibitor (SSRI) with rapid absorption (Tmax 1-2 hours) and IC50 of 1.12 nM for serotonin transporter inhibition. Major metabolites include desmethyldapoxetine and didesmethyldapoxetine, both equipotent SSRIs metabolized primarily via CYP2D6 and CYP3A4 pathways.​

Dapoxetine belongs to ATC group G04BX14 (other urologicals), distinguished from long-acting antidepressants by its pharmacokinetic profile optimized for intermittent “on-demand” administration. Regulatory classification varies by jurisdiction; available by prescription in approved markets, controlled or pharmacy-only elsewhere due to SSRI pharmacodynamics.​

This listing identifies chemical/pharmacological characteristics without describing indications, efficacy data, or clinical outcomes.

Product Specifications

• Product name: Dapoxeodin 30 mg 30 Tabs Odin Pharma

• Brand/manufacturer: Odin Pharma​

• Active compound: Dapoxetine hydrochloride (eq. to 30 mg dapoxetine)​

• Strength: 30 mg per film-coated tablet​

• Quantity per pack: 30 tablets​

• Dosage form: White, round, film-coated oral tablets

• Category: SSRI (G04BX14), prescription/pharmacy medicine per jurisdiction​

• Appearance: White, round tablets​

• Primary packaging: Blister strips in carton box​

• Secondary packaging: Branded carton with complete labeling

• Label elements: Product name, 30 mg strength, tablet count, batch number, expiry, manufacturer details​

Quality Control & Testing Standards

Dapoxetine tablets incorporate standard pharmaceutical controls including active ingredient assay, dissolution profiling, and film-coating uniformity per SSRI manufacturing requirements. Odin Pharma maintains batch-specific documentation supporting identity verification, potency consistency (30 mg dapoxetine HCl), and stability under labeled storage conditions.​

Excipient disclosure (including lactose presence) and molecular formula listing on packaging enable allergy screening and pharmacovigilance tracking. Film-coating ensures swallowability and light/moisture protection, distinguishing professional production from unregulated alternatives.​

Intended Use & Market Positioning

Dapoxeodin 30 mg 30 Tabs positions within adult male (18-64 years) pharmaceutical segments rather than general supplements, targeting informed consumers accessing regulated SSRI products through specialist channels. The 30 mg starting strength and 30-tablet count align with on-demand usage patterns observed in approved markets.​

Suitable for eCommerce platforms serving pharmacy/performance intersections where customers demonstrate product category familiarity. No administration timing, concomitant therapy warnings, or efficacy statements provided.

Packaging, Storage & Handling

Supplied in carton boxes containing blister strips of 30 film-coated tablets, providing light/moisture barrier and child-resistant features. Store below 25°C in dry conditions, protected from light; maintain blister integrity until immediate use.​

Access restricted to adults; pharmacies/facilities implement controlled dispensing per local pharmacy regulations. Expired/unused stock disposed via pharmaceutical take-back programs rather than household waste.

Purchasing & Availability Information

Dapoxeodin 30 mg 30 Tabs available through secure specialist platforms with encrypted checkout, age verification where required, and discreet outer packaging preserving privacy. Explicit “30 mg 30 Tabs” nomenclature prevents dosage confusion; batch transparency supports repeat procurement by verified customers.​

Domestic/regional fulfillment optimizes delivery timelines while minimizing customs exposure in compliant jurisdictions; stock positioning reflects pharmaceutical rather than supplement supply chain dynamics.

Legal & Regulatory Disclaimer

Dapoxetine constitutes prescription-only medicine in authorized markets, pharmacy-only or controlled elsewhere based on SSRI classification and potential for serotonergic interactions. Jurisdictional requirements govern dispensing, possession, import, and on-demand usage; non-compliance risks regulatory penalties.​

This description offers zero therapeutic claims, dosing guidance, or concomitant therapy recommendations. Buyer assumes complete responsibility for verifying Dapoxeodin 30 mg 30 Tabs complies with local pharmaceutical laws and maintaining appropriate storage/handling; no medical advice implied or provided.​